A pilot study of the management of uncomplicated candidemia with a standardized protocol of amphotericin B

Clinical Infectious Diseases

Volumn 29, Issue 6, 1999, Pages 1551-1556

  Fichtenbaum, Carl J ^a,d   German, Matthew ^a,b   Dunagan, W Claiborne ^a   Fraser, Victoria J ^a   Medoff, Gerald ^a   Diego, Jorge ^a,c   Powderly, William G ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b St Lukes Hospital   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; CANDIDA; CANDIDIASIS; CLINICAL PROTOCOL; ENDOPHTHALMITIS; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; RISK ASSESSMENT; STANDARDIZATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; AGED; AGED, 80 AND OVER; AMPHOTERICIN B; ANTIBIOTICS, ANTIFUNGAL; CANDIDA; CANDIDIASIS; CHEST PAIN; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PILOT PROJECTS; RECURRENCE; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0033390350     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313499     Document Type: Article

References (18)

1. 1. Jarvis WR. Epidemiology of nosocomial fungal infections, with emphasis on Candida species. Clin Infect Dis 1995;20:1526-30.
2. 2. Banerjee SN, Emori G, Culver DH, et al. Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. Am J Med 1991;91(Suppl 3B):86S-9S.
3. 3. Klein JJ, Watankunakorn C. Hospital-acquired fungemia. Am J Med 1979;67:51-8.
4. 4. Mitchell ABS, Magrath IT, Hosking G, Farthing CP. Survival of candida septicaemia with amphotericin B. Postgrad Med J 1972;48:436-40.
5. 5. Edwards, J. Candida species. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 4th ed. New York: Churchill Livingstone, 1990:2289-306.
6. 6. Rex JH, Bennett JE, Sugar AM, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. N Engl J Med 1994;331:1325-30.
7. 7. Anaissie EJ, Vartivarian SE, Abi-Said D, et al. Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study. Am J Med 1996;101:170-6.
8. 8. Donowitz LG, Hendley JO. Short-course amphotericin B therapy for candidemia in pediatric patients. Pediatrics 1995;95:888-91.
9. 9. Nguyen MH, Peacock JE, Tanner DC, et al. Therapeutic approaches in patients with candidemia: evaluation in a multicenter, prospective, observational study. Arch Intern Med 1995;155:2429-35.
10. 10. Abele-Horn M, Kopp A, Sternberg U, et al. A randomized study comparing fluconazole with amphotericin B/5-flucytosine for the treatment of systemic Candida infections in intensive care patients. Infection 1996;24: 426-32.
11. 11. Nguyen MH, Peacock JE, Morris AJ, et al. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am J Med 1996;100:617-23.
12. 12. Still JM, Belcher K, Law EJ. Management of candida septicaemia in a regional burn unit. Burns 1995;21:594-6.
13. 13. Edwards JE. International conference for the development of a consensus on the management and prevention of severe candidal infections. Clin Infect Dis 1997;25:43-59.
14. 14. Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC. Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality. Clin Infect Dis 1992;15:414-21.
15. 15. Medoff G, Dismukes WE, Meade RH, Moses JM. A new therapeutic approach to Candida infections. Arch Intern Med 1972;130:241-5.
16. 16. Louis, Thomas. Confidence intervals for a binomial parameter after observing no successes. American Statistician 1981;35:154.
17. 17. Wey SB, Mori M, Pfaller MA, et al. Hospital-acquired candidemia: the attributable mortality and excess length of stay. Arch Intern Med 1988;148: 2642-5.
18. 18. Driessen M, Ellis JB, Cooper PA, et al. Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial. Pediatr Infect Dis J 1996;15:1107-12.